AU2001259230A1 - Inhibition of polyclonal b cell activation and immunoglobulin class switching topathogenic autoantibodies by blocking cd1-mediated interactions - Google Patents
Inhibition of polyclonal b cell activation and immunoglobulin class switching topathogenic autoantibodies by blocking cd1-mediated interactionsInfo
- Publication number
- AU2001259230A1 AU2001259230A1 AU2001259230A AU5923001A AU2001259230A1 AU 2001259230 A1 AU2001259230 A1 AU 2001259230A1 AU 2001259230 A AU2001259230 A AU 2001259230A AU 5923001 A AU5923001 A AU 5923001A AU 2001259230 A1 AU2001259230 A1 AU 2001259230A1
- Authority
- AU
- Australia
- Prior art keywords
- topathogenic
- autoantibodies
- polyclonal
- inhibition
- blocking
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2833—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Transplantation (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20028500P | 2000-04-28 | 2000-04-28 | |
US60200285 | 2000-04-28 | ||
PCT/US2001/013728 WO2001082960A1 (en) | 2000-04-28 | 2001-04-27 | Inhibition of polyclonal b cell activation and immunoglobulin class switching to pathogenic autoantibodies by blocking cd1-mediated interactions |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001259230A1 true AU2001259230A1 (en) | 2001-11-12 |
Family
ID=22741064
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001259230A Abandoned AU2001259230A1 (en) | 2000-04-28 | 2001-04-27 | Inhibition of polyclonal b cell activation and immunoglobulin class switching topathogenic autoantibodies by blocking cd1-mediated interactions |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001259230A1 (en) |
WO (1) | WO2001082960A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2384439T3 (en) | 2002-06-14 | 2012-07-04 | Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Treatment and prevention procedures for colitis involving IL-13 and NK-T cells |
WO2005063819A2 (en) | 2003-12-23 | 2005-07-14 | Crucell Holland B.V. | Human binding molecule against cd1a |
EP1566439A1 (en) * | 2004-02-20 | 2005-08-24 | Nestec S.A. | Preventing or treating obesity |
WO2011099012A1 (en) * | 2010-02-12 | 2011-08-18 | Yeda Research And Development Co. Ltd. | Diagnosis of systemic lupus erythematosus (sle) |
JP2017503169A (en) | 2013-12-31 | 2017-01-26 | イエダ・リサーチ・アンド・デベロツプメント・カンパニー・リミテツド | Diagnosis of systemic lupus erythematosus using oligonucleotide antigens |
EP3265814B1 (en) | 2015-03-01 | 2020-11-18 | Immunarray Ltd. | Diagnosis of systemic lupus erythematosus using protein, peptide and oligonucleotide antigens |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5679347A (en) * | 1992-12-10 | 1997-10-21 | Brigham And Women's Hospital | Methods of isolating CD1-presented antigens, vaccines comprising CD1-presented antigens, and cell lines for use in said methods |
-
2001
- 2001-04-27 WO PCT/US2001/013728 patent/WO2001082960A1/en active Application Filing
- 2001-04-27 AU AU2001259230A patent/AU2001259230A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001082960A1 (en) | 2001-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL155340A0 (en) | HUMANIZED ANTI LYMPHOTOXIN-beta-RECEPTOR ANTIBODIES | |
AU1687500A (en) | Antihuman vegf monoclonal antibody | |
AU7863794A (en) | Antihuman tyrosinase monoclonal antibody | |
EP2336187B8 (en) | Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations | |
EP1071458A4 (en) | Humanized antibody and uses thereof | |
AU2001268855A1 (en) | Single-domain antigen-binding antibody fragments derived from llama antibodies | |
AU2002220843A1 (en) | Humanised antibodies and uses thereof | |
AU2002251562A1 (en) | Anti-CD40 monoclonal antibody | |
NO20031327L (en) | Closing device for blocking an opening | |
IL156030A0 (en) | Humanized antibodies | |
AU2001234125A1 (en) | Antibody library | |
AU2001291522A1 (en) | Shutter device for closing an aperture | |
AU2559799A (en) | Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies and uses of same | |
EP1399187A4 (en) | Uses of monoclonal antibody 8h9 | |
AU2001256325A1 (en) | Human and humanized fap-alpha-specific antibodies | |
DE69938095D1 (en) | Toroidal actuator | |
AU2001250970A1 (en) | Microphone with range switching | |
AU2001259230A1 (en) | Inhibition of polyclonal b cell activation and immunoglobulin class switching topathogenic autoantibodies by blocking cd1-mediated interactions | |
DE60121575D1 (en) | TAP WITH SECONDARY OPENING | |
AU2002216847A1 (en) | Epitopes of pai-1 | |
AU2001268040A1 (en) | Methods and compounds for inhibiting mrp1 | |
AU2002242447A1 (en) | Use of polyclonal immunoglobulins | |
AU8595298A (en) | Prediction, detection, and design of t cell epitopes | |
AU2001296915A1 (en) | Inhibition of antigen presentation with poorly catabolized polymers | |
ITPD20000192A0 (en) | POLYCLONAL ANTIBODIES |